Has Manikya Kuriti, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,176 in general payments to Manikya Kuriti, MD across 475 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Manikya Kuriti, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Manikya Kuriti, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Manikya Kuriti, MD

Endocrinology, Diabetes & Metabolism · Louisville, KYNPI 1124315858

Payments from drug & device makers

$7,176in general payments, 2019–2025

Across 475 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$1K
Sanofi-aventis U.S. LLC$623
Boehringer Ingelheim$607
Abbott$516
Lilly USA, LLC$472
Amgen$471
plus $3K from 34 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	103	$1,317
Sanofi-aventis U.S. LLC	31	$623
Boehringer Ingelheim	48	$607
Abbott	25	$516
Lilly USA, LLC	30	$472
Amgen	33	$471
AstraZeneca(2 entities)	26	$453
Amarin Pharma, Inc.	27	$403
Esperion Therapeutics, Inc.	18	$271
Medtronic(2 entities)	13	$253
AbbVie	12	$199
Merck	13	$196
Mannkind Corporation	15	$157
Xeris Pharmaceuticals, Inc.	7	$150
Amneal Pharmaceuticals LLC	10	$150
Insulet Corporation	8	$132
Dexcom, Inc.	6	$80
Shire North American Group Inc	5	$74
Radius Health, Inc.	5	$74
Johnson & Johnson	4	$62
Pfizer	3	$58
Bayer	4	$58
IBSA Pharma Inc.	4	$52
Antares Pharma, Inc.	3	$46
Valeritas, Inc.	3	$35
Clarus Therapeutics Inc.	2	$29
Recordati_rare_diseases_inc.	2	$27
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$25
Novartis	1	$25
Takeda Pharmaceuticals U.S.A., Inc.	2	$24
Corcept Therapeutics	1	$19
Lifescan, Inc.	1	$15
Kowa Pharmaceuticals America, Inc.	1	$15
Tandem Diabetes Care, Inc.	1	$14
Medicure Pharma Inc.	1	$13
Zealand Pharma US, Inc.	1	$13
Regeneron Healthcare Solutions, Inc.	1	$13
Senseonics, Incorporated	1	$12
Eisai Inc.	1	$12
Currax Pharmaceuticals LLC	1	$12

How this compares

$7,176 in reported general payments places this provider in the 60th percentile of 90 endocrinology, diabetes & metabolism providers in Kentucky.

See all endocrinology, diabetes & metabolism providers in Kentucky →

Medicare billing

Part B allowed, 2024

$53,944

Medicare patients

183

Services billed

691

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Louisville

Harold BaysLouisville$12.9M
Hisham AlrefaiLouisville$720K
Sathya KrishnasamyLouisville$263K
Jahangir CyrusLouisville$155K
Mehdi PoorkayLouisville$81K
Sri Prakash MokshagundamLouisville$73K
Stephen WintersLouisville$21K
Angelino YsonLouisville$15K
Mary SelfLouisville$14K
Omolara FakunleLouisville$13K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →